The global trauma products market size reached USD 9.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.4% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 9.6 Billion |
Market Forecast in 2033
|
USD 15.8 Billion |
Market Growth Rate (2025-2033) | 5.4% |
Trauma is a condition in which a body is damaged, injured, or dislocated by external forces, such as fractures, burns, sprains, dislocations, and strains. Trauma products are composed of innovative instruments, implants, and technologies designed to guarantee patients with musculoskeletal injuries a successful outcome. Pins, metal plates, rods, screws, and wires are commonly used as internal fixators for treating trauma while external fixators include stabilizing frames for bones broken in an accident. The majority of these components are made of metals or metal alloys, such as nickel, cobalt, chromium, and titanium. A variety of injuries that are treated with trauma products include hematomas, hydrocephalus, infections, and fractures of the skull.
The market is primarily driven by the growing incidences of degenerative bone diseases, such as osteoporosis, Paget’s disease, rheumatoid arthritis, and osteoarthritis. This can be attributed to the rising geriatric population that is susceptible to developing these diseases. In addition to this, the increasing adoption of minimally invasive surgeries and the augmenting government support to supply well-equipped instruments to trauma centers are resulting in higher product uptake. The widespread popularity of orthobiologics and regenerative pharmaceuticals in medical biotechnology is also providing an impetus to the market. Besides this, extensive research and development (R&D) activities, collaborations, and mergers and acquisitions (M&A) by key players for developing innovative trauma products are fueling the market. The market is further driven by a considerable rise in the medical expenditure, along with rapid developments in healthcare infrastructure. Some of the other factors creating a positive market outlook include the escalating prevalence of sports injuries and road accidents and the growing awareness regarding advanced trauma devices among patients.
IMARC Group provides an analysis of the key trends in each sub-segment of the global trauma products market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on product, surgical site and end user.
Breakup by Product:
Breakup by Surgical Site:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Acumed LLC (Colson Medical Inc.), Arthrex Inc., B. Braun Melsungen AG, Citieffe s.r.l, Double Medical Technology Inc., Enovis Corporation, Globus Medical Inc., Johnson & Johnson, Medartis AG, Orthofix Medical Inc., Smith & Nephew plc, Stryker Corporation and Zimmer Biomet.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Product, Surgical Site, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Acumed LLC (Colson Medical Inc.), Arthrex Inc., B. Braun Melsungen AG, Citieffe s.r.l, Double Medical Technology Inc., Enovis Corporation, Globus Medical Inc., Johnson & Johnson, Medartis AG, Orthofix Medical Inc., Smith & Nephew plc, Stryker Corporation and Zimmer Biomet |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global trauma products market was valued at USD 9.6 Billion in 2024.
We expect the global trauma products market to exhibit a CAGR of 5.4% during 2025-2033.
The growing incidences of degenerative bone diseases, such as osteoporosis, rheumatoid arthritis, osteoarthritis, etc., are primarily driving the global trauma products market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective treatment procedures for trauma to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the demand for trauma products.
Based on the product, the global trauma products market can be segmented into internal fixators, external fixators, and others. Currently, internal fixators hold the majority of the total market share.
Based on the surgical site, the global trauma products market has been divided into upper extremities and lower extremities, where lower extremities currently exhibit a clear dominance in the market.
Based on the end user, the global trauma products market can be categorized into hospitals and trauma centers and ambulatory surgery center. Currently, hospitals and trauma centers account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global trauma products market include Acumed LLC (Colson Medical Inc.), Arthrex Inc., B. Braun Melsungen AG, Citieffe s.r.l, Double Medical Technology Inc., Enovis Corporation, Globus Medical Inc., Johnson & Johnson, Medartis AG, Orthofix Medical Inc., Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet.